Ceftazidime-avibactam: are we safe from class A carbapenemase producers’ infections?
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Microbiology
Link
https://link.springer.com/content/pdf/10.1007/s12223-021-00918-5.pdf
Reference131 articles.
1. Aktaş Z, Kayacan C, Oncul O (2012) In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 39:86–89. https://doi.org/10.1016/j.ijantimicag.2011.09.012
2. Antinori E, Unali I, Bertoncelli A, Mazzariol A (2020) Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene. Clin Microbiol Infect 26:946.e1. https://doi.org/10.1016/j.cmi.2020.02.007
3. Antonelli A, Giani T, Di Pilato V et al (2019) KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues. J Antimicrob Chemother 74:2464–2466. https://doi.org/10.1093/jac/dkz156
4. Appel TM, Mojica MF, De La Cadena E et al (2020) In vitro susceptibility to ceftazidime/avibactam and comparators in clinical isolates of Enterobacterales from five Latin American countries. Antibiotics (2079–6382) 9:62. https://doi.org/10.3390/antibiotics9020062
5. Barnes MD, Winkler ML, Taracila MA et al (2017) Klebsiella pneumoniae carbapenemase-2 (KPC-2), substitutions at ambler position Asp179, and resistance to ceftazidime-avibactam: unique antibiotic-resistant phenotypes emerge from β-lactamase protein engineering. mBio 8:e00528–17, /mbio/8/5/e00528–17.atom. https://doi.org/10.1128/mBio.00528-17
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance;International Journal of Antimicrobial Agents;2024-09
2. Detection of polymyxins resistance among Enterobacterales: evaluation of available methods and proposal of a new rapid and feasible methodology;Annals of Clinical Microbiology and Antimicrobials;2023-08-10
3. Whole-Genome Sequencing and Molecular Analysis of Ceftazidime–Avibactam-Resistant KPC-Producing Klebsiella pneumoniae from Intestinal Colonization in Elderly Patients;Antibiotics;2023-08-03
4. Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study;Open Forum Infectious Diseases;2023-06-30
5. The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase;Antibiotics;2023-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3